Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Ocugen revenue
Ocugen's revenue is $4.1 million.
What is Ocugen's revenue?
- Ocugen's revenue growth from 2013 to 2024 is 50,587.5%.
- Ocugen has 49 employees, and the revenue per employee ratio is $82,755.
- Ocugen's peak quarterly revenue was $3.7M in 2023(q3).
- Ocugen peak revenue was $6.0M in 2023.
- Ocugen annual revenue for 2023 was 6.0M, 142.6% growth from 2022.
- Ocugen annual revenue for 2024 was 4.1M, -32.82% growth from 2023.
On this page
Zippi applies for you, and finds you a job.
Ocugen historical revenue
Ocugen's peak revenue was $6.0M in 2023. The peak quarterly revenue was $3.7M in 2023(q3).
Ocugen's revenue increased from $8.0k in 2013 to $4.1M currently. That's a 50,587.5% change in annual revenue.
Ocugen annual revenue
Ocugen annual revenue over time
| Fiscal year / year | Ocugen revenue |
|---|---|
| 2013 | $8,000 |
| 2020 | $43,000 |
| 2022 | $2.5M |
| 2023 | $6.0M |
| 2024 | $4.1M |
How accurately did Ocugen's revenue projections match actual performance?
Ocugen annual growth
Ocugen saw the greatest revenue growth in 2020, when revenue increased by 437.5%.
Ocugen had the lowest revenue growth in 2020, when revenue changed by 437.5%.
Ocugen annual growth rate over time
| Year | Ocugen growth |
|---|---|
| 2020 | 438%↑ |
| 2022 | 5686%↑ |
| 2023 | 143%↑ |
| 2024 | -33%↓ |
Ocugen quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Ocugen quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2020 | - | $43,000 | - | - |
| 2022 | - | - | - | $2.5M |
| 2023 | $443,000 | $485,000 | $3.7M | $1.4M |
| 2024 | $1.0M | $1.1M | $1.1M | $764,000 |
Ocugen jobs nearby
Do you work at Ocugen?
Did Ocugen meet its revenue projections?
Ocugen financial information
| CEO | Shankar Musunuri |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 49 |
| Date Founded | 2013 |
| Headquarters | Malvern, Pennsylvania |
| Number of Locations | 1 |
| Revenue | $4.1M |
| Net Income | -$81,351,000 |
| Tax Rate | 0.0% |
| Total Assets | $108,632,000 |
| Ticker | OCGN |
Ocugen jobs you might like
Ocugen financing
Ocugen received early financing of $23.0M on 2021-02-10.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $23M | 02/2021 |
| Post Ipo Equity | $100M | 04/2021 |
Ocugen investors
| Investors | Security type |
|---|---|
| ROTH Capital Partners | Post Ipo Equity |
Ocugen competitors
Ocugen's top competitor, Kodiak Sciences, earned an annual revenue of $43.0B.
Ocugen's smallest competitor is ONL Therapeutics with revenue of $150.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Graybug | - | $1.6M | 37 | - |
| Adverum Biotechnologies | - | $3.6M | 188 | - |
| Oyster Point Pharma | - | $2.2M | 86 | - |
| Ophthotech | - | $210.0M | 58 | - |
| Kodiak Sciences | - | $43.0B | 28 | - |
| ONL Therapeutics | - | $150,000 | 28 | - |
| Mustang Bio | - | $2.4M | 38 | - |
| Leap Therapeutics | - | $1.5M | 30 | - |
| Angion | - | $28.3M | 20 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Ocugen, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Ocugen. The employee data is based on information from people who have self-reported their past or current employments at Ocugen. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Ocugen. The data presented on this page does not represent the view of Ocugen and its employees or that of Zippia.
Ocugen may also be known as or be related to OCUGEN, INC., Ocugen, Ocugen Inc and Ocugen, Inc.